Wendy L Dixon - Net Worth and Insider Trading
Wendy L Dixon Net Worth
The estimated net worth of Wendy L Dixon is at least $2 Million dollars as of 2024-04-26. Wendy L Dixon is the Director of Alkermes PLC and owns about 41,300 shares of Alkermes PLC (ALKS) stock worth over $1 Million. Wendy L Dixon is also the Director of Incyte Corp and owns about 17,259 shares of Incyte Corp (INCY) stock worth over $883,316. Details can be seen in Wendy L Dixon's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Wendy L Dixon has not made any transactions after 2021-12-23 and currently still holds the listed stock(s).
Transaction Summary of Wendy L Dixon
Wendy L Dixon Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Wendy L Dixon owns 13 companies in total, including Incyte Corp (INCY) , Arvinas Inc (ARVN) , and bluebird bio Inc (BLUE) among others .
Click here to see the complete history of Wendy L Dixon’s form 4 insider trades.
Insider Ownership Summary of Wendy L Dixon
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
INCY | Incyte Corp | 2021-12-23 | director |
ARVN | Arvinas Inc | 2020-06-29 | director |
BLUE | bluebird bio Inc | 2013-06-18 | director |
VYGR | Voyager Therapeutics Inc | 2017-01-01 | director |
ALKS | Alkermes PLC | 2021-06-10 | director |
SESN | Sesen Bio Inc | 2014-10-22 | director |
OREXQ | Orexigen Therapeutics Inc | 2015-06-09 | director |
XRAY | Dentsply Sirona Inc | 2005-07-01 | director |
BMY | Bristol-Myers Squibb Co | 2003-09-10 | CMO & Pres & Global Marketing |
BDTX | Black Diamond Therapeutics Inc | 2022-04-06 | director |
IOVA | Iovance Biotherapeutics Inc | 2022-06-10 | director |
ZVRA | Zevra Therapeutics Inc | 2023-04-25 | director |
CARM | CARISMA Therapeutics Inc | 2014-10-22 | director |
Wendy L Dixon Latest Holdings Summary
Wendy L Dixon currently owns a total of 2 stocks. Among these stocks, Wendy L Dixon owns 41,300 shares of Alkermes PLC (ALKS) as of June 10, 2021, with a value of $1 Million and a weighting of 53.33%. Wendy L Dixon also owns 17,259 shares of Incyte Corp (INCY) as of December 23, 2021, with a value of $883,316 and a weighting of 46.67%.
Latest Holdings of Wendy L Dixon
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ALKS | Alkermes PLC | 2021-06-10 | 41,300 | 24.44 | 1,009,372 |
INCY | Incyte Corp | 2021-12-23 | 17,259 | 51.18 | 883,316 |
Holding Weightings of Wendy L Dixon
Wendy L Dixon Form 4 Trading Tracker
According to the SEC Form 4 filings, Wendy L Dixon has made a total of 2 transactions in Alkermes PLC (ALKS) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Alkermes PLC is the sale of 25,000 shares on June 10, 2021, which brought Wendy L Dixon around $625,000.
According to the SEC Form 4 filings, Wendy L Dixon has made a total of 3 transactions in Incyte Corp (INCY) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Incyte Corp is the sale of 20,000 shares on December 23, 2021, which brought Wendy L Dixon around $441,000.
Insider Trading History of Wendy L Dixon
- 1
Wendy L Dixon Trading Performance
GuruFocus tracks the stock performance after each of Wendy L Dixon's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Wendy L Dixon is 40.11%. GuruFocus also compares Wendy L Dixon's trading performance to market benchmark return within the same time period. The performance of stocks bought by Wendy L Dixon within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Wendy L Dixon's insider trading performs compared to the benchmark.
Performance of Wendy L Dixon
Average Return
35.17%
Outperforming Transactions
100%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 9.81 | 40.11 | 76 | 35.17 | 94.82 | 77.05 |
Relative Return to S&P 500(%) | 9.52 | 28.18 | 68.7 | 23.35 | 73.19 | 58.22 |
Wendy L Dixon Ownership Network
Ownership Network List of Wendy L Dixon
Ownership Network Relation of Wendy L Dixon
Wendy L Dixon Owned Company Details
What does Incyte Corp do?
Who are the key executives at Incyte Corp?
Wendy L Dixon is the director of Incyte Corp. Other key executives at Incyte Corp include EVP & Chief Medical Officer Steven H Stein , EVP GPS & BD & & Licensing Vijay K Iyengar , and Principal Accounting Officer Thomas Tray .
Incyte Corp (INCY) Insider Trades Summary
Over the past 18 months, Wendy L Dixon made no insider transaction in Incyte Corp (INCY). Other recent insider transactions involving Incyte Corp (INCY) include a net sale of 57,275 shares made by Steven H Stein , a net sale of 24,981 shares made by Vijay K Iyengar , and a net sale of 2,500 shares made by Thomas Tray .
In summary, during the past 3 months, insiders sold 0 shares of Incyte Corp (INCY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 155,648 shares of Incyte Corp (INCY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 155,648 shares.
Incyte Corp (INCY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Incyte Corp Insider Transactions
Wendy L Dixon Mailing Address
Above is the net worth, insider trading, and ownership report for Wendy L Dixon. Currently GuruFocus does not have mailing address information for Wendy L Dixon.